POMSnet Falcon MES Dashboard
POMSnet Falcon Dives Into Pharma and Biotech GMP Facilities Across the Globe
04 janv. 2022 09h00 HE | POMS
HERNDON, Va., Jan. 04, 2022 (GLOBE NEWSWIRE) -- POMS Corporation releases POMSnet Falcon 2021.2 MES Dashboard and Analytics. POMSnet Falcon is perched to become the GMP facility standard for...
NOVARTIS logo.jpg
Novartis to acquire Gyroscope Therapeutics, adding a one-time gene therapy that could transform care for geographic atrophy, a leading cause of blindness
22 déc. 2021 02h00 HE | Novartis Pharma AG
There are no currently approved therapies impacting disease progression for the up to 8 million people suffering from geographic atrophy (GA)1,2 Acquisition will add GT005 to the Novartis portfolio,...
NOVARTIS logo.jpg
Novartis announces T-Charge™, next-generation CAR-T platform with first-in-human data at ASH 2021
13 déc. 2021 14h45 HE | Novartis Pharma AG
T-Charge, a next-generation platform that aims to revolutionize CAR-T cell therapy, will serve as foundation for various investigational CAR-T therapies Early data from first-in-human dose-escalation...
NOVARTIS logo.jpg
Novartis provides update on BELINDA study investigating Kymriah® as second-line treatment in aggressive B-cell non-Hodgkin lymphoma
24 août 2021 01h15 HE | Novartis Pharma AG
Phase III BELINDA study did not meet primary endpoint of event-free survival for patients with aggressive B-cell non-Hodgkin lymphoma who had primary refractory disease or who relapsed within 12...
AGC Biologics Appoin
AGC Biologics Appoints Tony Fraij as the new General Manager/Site Head of the Longmont, Colorado Site
09 août 2021 13h00 HE | AGC Biologics
LONGMONT, Aug. 09, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has announced a new leadership appointment...
AGC Biologics Acquires Commercial Facility, Expanding Cell & Gene Therapy Global Service Offerings
05 août 2021 12h00 HE | AGC Biologics
Seattle, Aug. 05, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced the finalization of the purchase of...
TIP_link_300x300.jpg
GMP Cytokines Market to Outstrip $158.13 Million by 2027 Growing Sturdy at 8.1% CAGR - COVID-19 Impact and Global Analysis by TheInsightPartners.com
11 juin 2021 09h38 HE | The Insight Partners
Pune, India., June 11, 2021 (GLOBE NEWSWIRE) -- GMP Cytokines Market: Key InsightsAccording to our new research study on “GMP Cytokines Market to 2027 – Global Analysis and Forecast – by Type,...
AGC Inc. Receives Be
AGC Inc. Receives Best Acquisition Award for Adding the Former MolMed into AGC Biologics
19 mai 2021 13h10 HE | AGC Biologics
Seattle, May 19, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced their win of the M&A Award for...
Rentschler Biopharma logo from PR.jpg
Rentschler Biopharma establishes Center of Excellence for cell and gene therapy in the UK
11 févr. 2021 04h10 HE | Rentschler Biopharma SE
New enterprise, Rentschler ATMP Ltd., is part of continuous innovation at Rentschler Biopharma and supports ongoing strategic international expansionCenter of Excellence to address the gap in capacity...
Rentschler Biopharma logo from PR.jpg
Rentschler Biopharma to build new cell and gene therapy capabilities in the UK Rentschler Biopharma will establish their ATMP development and manufacturing capabilities at the Cell and Gene Therapy Catapult facility in StevenageAgreement confirms UK’s global attractiveness for...